DRMA · Company research
Dermata Therapeutics, Inc. Common Stock (DRMA): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
18records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Why Is Dermata Therapeutics Stock Gaining Thursday? - Benzinga | Why Is Dermata Therapeutics Stock Gaining Thursday? Benzinga | View source ↗ | Benzinga | Oct 15, 2026 | neutral | 0 | 0.6 |
| Top stock movements in today's session. - ChartMill | Top stock movements in today's session. ChartMill | View source ↗ | ChartMill | Oct 15, 2026 | neutral | 0 | 0.6 |
| Skin in the Game for Dermata Therapeutics, Inc. (NASDAQ:DRMA) Big Gains on Positive Topline Results from Cosmetic Study - Investorideas.com | Skin in the Game for Dermata Therapeutics, Inc. (NASDAQ:DRMA) Big Gains on Positive Topline Results from Cosmetic Study Investorideas.com | View source ↗ | Investorideas.com | Oct 15, 2026 | neutral | 0 | 0.6 |
| 93% said the once-weekly skin treatment was comparable to a professional office procedure. - Stock Titan | 93% said the once-weekly skin treatment was comparable to a professional office procedure. Stock Titan | View source ↗ | Stock Titan | Oct 15, 2026 | neutral | 0 | 0.6 |
| Dermata Therapeutics (DRMA) Drops 3.34% to $0.86 as Traders Eye $0.82 Support - Low Beta Factor - https://www.dars.gov.et/ | Dermata Therapeutics (DRMA) Drops 3.34% to $0.86 as Traders Eye $0.82 Support - Low Beta Factor https://www.dars.gov.et/ | View source ↗ | https://www.dars.gov.et/ | Oct 14, 2026 | neutral | 0 | 0.6 |
| Dermata Therapeutics (DRMA) Drops 8.22% to $1.34 as Selling Pressure Drags Micro-Cap Biotech Lower - Trend Reversal Picks - dars.gov.et | Dermata Therapeutics (DRMA) Drops 8.22% to $1.34 as Selling Pressure Drags Micro-Cap Biotech Lower - Trend Reversal Picks dars.gov.et | View source ↗ | dars.gov.et | Aug 29, 2026 | neutral | 0 | 0.6 |
| Dermata (NASDAQ: DRMA) ends Nasdaq listing for warrants - Stock Titan | Dermata (NASDAQ: DRMA) ends Nasdaq listing for warrants Stock Titan | View source ↗ | Stock Titan | Aug 17, 2026 | neutral | 0 | 0.6 |
| DRMA Stock Draws Traders As Dermata Pivots To Skincare - StocksToTrade | DRMA Stock Draws Traders As Dermata Pivots To Skincare StocksToTrade | View source ↗ | StocksToTrade | Aug 12, 2026 | neutral | 0 | 0.6 |
| Dermata Therapeutics Shares Jump 28.73% Pre-Market - Dermata Therapeutics (NASDAQ:DRMA) - Benzinga | Dermata Therapeutics Shares Jump 28.73% Pre-Market - Dermata Therapeutics (NASDAQ:DRMA) Benzinga | View source ↗ | Benzinga | Aug 12, 2026 | neutral | 0 | 0.6 |
| $DRMA stock is up 18% today. Here's what we see in our data. - Quiver Quantitative | $DRMA stock is up 18% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 12, 2026 | neutral | 0 | 0.6 |
| DRMA Stock Draws Traders As Dermata Pivots To Skincare Launch - StocksToTrade | DRMA Stock Draws Traders As Dermata Pivots To Skincare Launch StocksToTrade | View source ↗ | StocksToTrade | Aug 12, 2026 | neutral | 0 | 0.6 |
| DERMATA THERAPEUTICS ($DRMA) Releases Q2 2026 Earnings, Stock Rises - Quiver Quantitative | DERMATA THERAPEUTICS ($DRMA) Releases Q2 2026 Earnings, Stock Rises Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 11, 2026 | neutral | 0 | 0.6 |
| Dermata's Tome Skincare Product Is Designed for Once-Weekly Use - Stock Titan | Dermata's Tome Skincare Product Is Designed for Once-Weekly Use Stock Titan | View source ↗ | Stock Titan | Aug 11, 2026 | neutral | 0 | 0.6 |
| DRMA Forecast — Price Target — Prediction for 2027 - TradingView | DRMA Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Sales rise as DRMA posts IDR 652.58 billion net profit in 2025 - IDNFinancials | Sales rise as DRMA posts IDR 652.58 billion net profit in 2025 IDNFinancials | View source ↗ | IDNFinancials | Mar 13, 2026 | neutral | 0 | 0.6 |
| Why Did Dermata Therapeutics Stock Surge 22% Pre-Market Today? - Stocktwits | Why Did Dermata Therapeutics Stock Surge 22% Pre-Market Today? Stocktwits | View source ↗ | Stocktwits | Dec 24, 2025 | neutral | 0 | 0.6 |
| Dermata Therapeutics, Inc. (DRMA) Stock Price, News, Quote & History - Yahoo! Finance Canada | Dermata Therapeutics, Inc. (DRMA) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Nov 13, 2025 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Aug 2, 2024 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.